1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Spatial immunophenotyping of the tumour microenvironment in non-small cell lung cancer
(
- Contribution to journal › Article
- 2022
-
Mark
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
(
- Contribution to journal › Article
- 2013
-
Mark
Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
(
- Contribution to journal › Article
- 2012
-
Mark
CD99 is a novel prognostic stromal marker in non-small cell lung cancer
(
- Contribution to journal › Article
- 2011
-
Mark
Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
(
- Contribution to journal › Article
- 2008
-
Mark
Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
(
- Contribution to journal › Article